AMNEAL PHARMACEUTICALS, INC. Income Taxes Receivable, Current
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Income Taxes Receivable, Current of $11.88 million as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Notes › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2021-03-01
- 2020-12-31: Income Taxes Receivable, Current $11.88M.
- 2019-12-31: Income Taxes Receivable, Current $13.74M.
- 2018-12-31: Income Taxes Receivable, Current $29.63M.
- 2018-09-30: Income Taxes Receivable, Current $74.78M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2020-12-31 | $11.88M 10-K · filed 2021-03-01 |
| 2019-12-31 | $13.74M 10-K · filed 2021-03-01 |
| 2018-12-31 | $29.63M 10-K · filed 2020-03-02 |
| 2018-09-30 | $74.78M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $68.33M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |